SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001031927-11-000004
Filing Date
2011-01-11
Accepted
2011-01-11 16:53:08
Documents
3
Period of Report
2011-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K - 2011-01-05 form8k-20110105.htm 8-K 41805
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 53567
3 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 29768
  Complete submission text file 0001031927-11-000004.txt   127261
Mailing Address 10 FORGE PARKWAY FRANKLIN MA 02038
Business Address 10 FORGE PARKWAY FRANKLIN MA 02038 508 553-8850
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23017 | Film No.: 11523393
SIC: 3845 Electromedical & Electrotherapeutic Apparatus